Literature DB >> 2547348

Large cell carcinoma of the lung: a highly aggressive tumor with dismal prognosis.

R S Downey1, C W Sewell, K A Mansour.   

Abstract

A retrospective review was made of 96 consecutive patients with large cell carcinoma of the lung admitted to Emory University Hospital over 10 years. Only 10 patients were seen with stage I lesions favorable for resection. The remainder were treated primarily with irradiation or chemotherapy. Mean survival for clinical stage I patients was 15.9 months; stage IIIA patients, 7.9 months; stage IIIB patients, 7.1 months; and stage IV patients, 5.8 months. Only 1 patient survived for 5 years. This distinct and highly aggressive form of lung cancer most commonly is seen at an advanced stage and is associated with an unusually dismal prognosis regardless of the method of treatment employed.

Entities:  

Mesh:

Year:  1989        PMID: 2547348     DOI: 10.1016/0003-4975(89)90007-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Accelerated apoptosis and low bcl-2 expression associated with neuroendocrine differentiation predict shortened survival in operated large cell carcinoma of the lung.

Authors:  A K Eerola; H Ruokolainen; Y Soini; H Raunio; P Pääkkö
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

2.  Clinical features of bronchogenic large cell carcinoma confirmed by surgical resection.

Authors:  Moo Suk Park; Dong Hwan Shin; Kyung Young Chung; Jae Hee Cheong; Jae Ho Chung; Do Hoon Kim; Se Kyu Kim; Joon Chang; Joo Hang Kim; Sung Kyu Kim; Young Sam Kim
Journal:  Korean J Intern Med       Date:  2003-12       Impact factor: 2.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.